- Report
- January 2024
- 253 Pages
Global
From €5228EUR$5,500USD£4,471GBP
- Report
- March 2024
- 187 Pages
Global
From €3207EUR$3,374USD£2,743GBP
€3564EUR$3,749USD£3,048GBP
- Report
- November 2023
- 312 Pages
Global
From €5265EUR$5,732USD£4,350GBP
- Report
- February 2024
- 400 Pages
Global
From €4753EUR$5,000USD£4,065GBP
- Report
- May 2023
- 120 Pages
Global
From €5656EUR$5,950USD£4,837GBP
- Report
- March 2024
- 196 Pages
Global
From €4706EUR$4,950USD£4,024GBP
- Report
- March 2024
- 293 Pages
Global
From €4706EUR$4,950USD£4,024GBP
- Report
- March 2023
- 260 Pages
Global
From €4562EUR$4,799USD£3,901GBP
- Report
- March 2023
- 165 Pages
Global
From €4562EUR$4,799USD£3,901GBP
- Report
- March 2024
- 221 Pages
Global
From €2329EUR$2,450USD£1,992GBP
- Report
- November 2023
- 170 Pages
Global
From €2139EUR$2,250USD£1,829GBP
- Report
- March 2024
- 184 Pages
Global
From €3207EUR$3,374USD£2,743GBP
€3564EUR$3,749USD£3,048GBP
- Report
- February 2024
- 209 Pages
Global
From €3422EUR$3,600USD£2,927GBP
- Report
- February 2024
- 145 Pages
Global
From €4064EUR$4,275USD£3,475GBP
€4515EUR$4,750USD£3,862GBP
- Report
- December 2023
Global
From €7130EUR$7,500USD£6,097GBP
- Report
- August 2023
- 49 Pages
Global
From €2377EUR$2,500USD£2,032GBP
- Training
- June 2023
- 2 Days
Global
From €1401EUR$1,474USD£1,198GBP
- Report
- March 2024
- 200 Pages
Global
From €3798EUR$3,995USD£3,248GBP
- Report
- March 2024
- 500 Pages
Global
From €3798EUR$3,995USD£3,248GBP
- Report
- March 2024
- 400 Pages
Global
From €3798EUR$3,995USD£3,248GBP
The biologic market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs. Biologic drugs are made from living organisms, such as proteins, nucleic acids, and cells, and are used to treat a variety of diseases. These drugs are typically more complex and expensive to produce than traditional small-molecule drugs. The biologic market is highly competitive, with many companies vying for market share.
The biologic market is divided into two main segments: therapeutic biologics and biosimilars. Therapeutic biologics are drugs that are developed to treat a specific disease or condition, while biosimilars are drugs that are similar to existing biologic drugs but are not identical.
Some of the major players in the biologic market include Amgen, Biogen, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development, production, and marketing of biologic drugs. Show Less Read more